Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase

Abstract

In middle-aged and old adults from the general population, NAFLD is associated with an independent risk of identifying hypertension and high-normal systolic BP. Detection of NAFLD, even with normal ALT levels, should serve as an opportunity to identify metabolic and BP abnormalities and intensify lifestyle modification.

Hypertension and non‐alcoholic fatty liver disease proven by transient elastography

“…A total of 39.83% of the subjects had been diagnosed with NAFLD. Our findings are inconsistent with another study that reported a lower prevalence of NAFLD (19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34). 11,15,16 A possible explanation for the different prevalence may originate from the characteristics of the studied populations.…”

“…As Lopez‐Suarez et al . reported, approximately 50% of hypertensive patients have NAFLD . Compared to the non‐fatty liver group, the fatty liver group has a higher prevalence of hypertension .…”

Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis

“…Metabolic disorders such as hypertension, hyperlipidemia, diabetes, gallstones, and central obesity are known risk factors for NAFLD [2,5,6]. Thyroid hormones regulate all metabolic pathways, acting on protein, carbohydrates, and lipid metabolism.…”

Prevalence of Disease Spectrum and Sick Leave Time Associated with Illness in Helicopter Pilots

“…Therefore, the importance of preventing and controlling this disease cannot be overemphasized. Moreover, fatty liver is closely related to metabolic syndromes, including obesity, glucose intolerance, dyslipidemia, and hypertension ( 11 ), and may be further associated with cardiovascular diseases such as atherosclerosis and coronary heart disease ( 12 ). Therefore, to ensure fl ight safety, great attention should be paid to the screening, treatment, and monitoring of pilots at risk of fatty liver.…”